Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Rheumatology
•
General Rheumatology
•
JAK Inhibitors
•
Obstetrics & Gynecology
Is it safe to use estradiol in a patient who is currently being treated with a JAK inhibitor?
Related Questions
How do you evaluate and manage patients with lupus who are having issues with decreased libido?
How would you approach management of a patient with ankylosing spondylitis who was doing well on tofacitinib, but experienced a STEMI while on therapy?
In an infant whose mother resumes TNF inhibitor therapy (e.g., adalimumab, infliximab, certolizumab) after delivery and is breastfeeding, do you recommend delaying live vaccinations?
For patients with rheumatic disease on chronic glucocorticoids, is there a role for alternate-day dosing during tapering, or do you taper by lowering the daily dose only?
In light of recent measles outbreaks, have you adjusted your vaccination counseling or preventive strategies for adult immunocompromised patients?
What are useful clinical features that help differentiate mechanics hands from other conditions such as hand dermatitis or psoriasis?
Is there any indication for IVIG in immunocompromised patients with only decreased IgM and/or IgA levels?
Would you always pursue excisional biopsy versus core biopsy to confirm Kikuchi's disease?
When starting stress dose steroids for patient with primary adrenal insufficiency, how do you decide whether to start hydrocortisone 100 mg every 8 hours versus 50 mg every 6 hours?
With the increasing availability of biosimilars and their adoption onto payer formularies, how do you approach selection among available biosimilars in clinical practice?
